- Kreuels B, Wichmann D, Emmerich P et al.A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia. N Engl J Med2014 Oct 22.Doi: https://doi.org/10.1056/NEJMoa1411677.
- Qiu X, Wong G, Audet J et al.Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature2014;514: 47–53.
- WHO Ebola Response Team.Ebola virus disease in West Africa–the first 9 months of the epidemic and forward projections. N Engl J Med2014;371: 1481–1495.
- Kanapathipillai R, Restrepo AM, Fast P et al.Ebola Vaccine - An Urgent International Priority. N Engl J Med2014 Oct 7.Doi: https://doi.org/10.1056/NEJMp1412166.
- Cohen J.Infectious disease. Ebola vaccine: little and late. Science2014;345: 1441–1442.
- Tscherne DM.Manicassamy B, Garcia-Sastre A.An enzymatic virus-like particle assay for sensitive detection of virus entry. J Virol Methods2010;163: 336–343.
- Huang R, Southall N, Wang Y et al.The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med2011;3: 80ps16.
- Wang Y, Jadhav A, Southal N, Huang R, Nguyen DT.A grid algorithm for high throughput fitting of dose-response curve data. Curr Chem Genomics2010;4: 57–66.
- Martinez O, Johnson J, Manicassamy B et al.Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cell Microbiol2010;12: 148–157.
- Hoy SM, Keam SJ.Dronedarone. Drugs2009;69: 1647–1663.
- Martínez-Gil L, Ayllon J, Ortigoza MB et al.Identification of small molecules with type I interferon inducing properties by high-throughput screening. PloS One2012;7: e49049.
- Wool-Lewis RJ, Bates P.Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol1998;72: 3155–3160.
- Dube D, Schornberg KL, Shoemaker CJ et al.Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry. Proc Natl Acad Sci USA2010;107: 16637–16642.
- Ruthel G, Demmin GL, Kallstrom G et al.Association of ebola virus matrix protein VP40 with microtubules. J Virol2005;79: 4709–4719.
- Yonezawa A, Cavrois M, Greene WC.Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J Virol2005;79: 918–926.
- Johansen LM, Brannan JM, Delos SE et al.FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med2013;5: 190ra79.
- Jang ER, Lim SJ, Lee ES et al.The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen. Oncogene2004;23: 1724–1736.
- Levenson AS, Jordan VC.Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J Steroid Biochem Mol Biol1994;51: 229–239.
- Touitou I, Mathieu M, Rochefort H.Stable transfection of the estrogen receptor cDNA into Hela cells induces estrogen responsiveness of endogenous cathepsin D gene but not of cell growth. Biochem Biophys Res Commun1990;169: 109–115.
- Laird GM, Eisele EE, Rabi SA, Nikolaeva D, Siliciano RF.A novel cell-based high-throughput screen for inhibitors of HIV-1 gene expression and budding identifies the cardiac glycosides. J Antimicrob Chemother2014;69: 988–994.
- Xia M, Huang R, Sakamuru S et al.Identification of repurposed small molecule drugs for chordoma therapy. Cancer Biol Ther2013;14: 638–647.
- Wang Z, Zheng M, Li Z et al.Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition. Cancer Res2009;69: 6556–6564.
- Wong RW, Balachandran A, Ostrowski MA, Cochrane A.Digoxin suppresses HIV-1 replication by altering viral RNA processing. PLoS Pathog2013;9, e1003241.
- Bryson HM, Palmer KJ, Langtry HD, Fitton A.Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias. Drugs1993;45: 85–130.
- Leone Roberti Maggiore U, Valenzano Menada M, Venturini PL, Ferrero S.The potential of sunitinib as a therapy in ovarian cancer. Expert Opin Investig Drugs2013;22: 1671–1686.
- Bhattacharyya S, Warfield KL, Ruthel G, Bavari S, Aman MJ, Hope TJ.Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology2010;401: 18–28.
- García M, Cooper A, Shi W et al.Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase. Sci Transl Med2012;4: 123ra124.
- Gehring G, Rohrmann K, Atenchong N et al.The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. J Antimicrob Chemother2014;69: 2123–2131.
- Oestereich L, Lüdtke A, Wurr S, Rieger T, Muñoz-Fontela C, Günther S.Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res2014;105: 17–21.
- Madrid PB, Chopra S, Manger ID et al.A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PloS One2013;8: e60579.
- Shoemaker CJ, Schornberg KL, Delos SE et al.Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PloS One2013;8: e56265.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research